US equities
|
NVDA
$127.80
▼-12.45%
ANT
$87.19
▼-10.27%
MU
$598.23
▼-13.36%
AMD
$431.09
▼-11.88%
AAPL
$344.64
▼-1.31%
SPCX
$129.44
▼-6.49%
MSFT
$487.23
▼-2.22%
AMZN
$247.97
▼-3.65%
NVDA
$127.80
▼-12.45%
ANT
$87.19
▼-10.27%
MU
$598.23
▼-13.36%
AMD
$431.09
▼-11.88%
AAPL
$344.64
▼-1.31%
SPCX
$129.44
▼-6.49%
MSFT
$487.23
▼-2.22%
AMZN
$247.97
▼-3.65%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Phase 3 Clinical Trial
Recent news which mentions Phase 3 Clinical Trial
UK Supports Psychedelic Research With Phase 3 Trial In Federal Health Sites
December 13, 2022
Tickers
AWKNF
Tags
Benzinga
Penny Stocks
Ketamine/Assisted Therapy
From
Benzinga
MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next
November 17, 2022
Tags
Phase 3 Clinical Trial
News
Cannabis
From
Benzinga
Compass Pathways Will Lead Two Concurrent Phase 3 Trials On Psilocybin-Assisted Therapy For Depression
October 12, 2022
Tickers
CMPS
Tags
Phase 3 Clinical Trial
TRD
Psychedelics
From
Benzinga